The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Activation of Phosphatidylinositol 3-Kinase by Membrane Localization of p110α Predisposes Mammary Glands to Neoplastic Transformation
Published version of a preprint
Abstract
Phosphatidylinositol 3-kinases (PI3K) constitute important regulators of various signaling pathways with relevance in cancer. Enhanced activation of p110α, the catalytic subunit of PI3K, was found in a high proportion of many human tumor types. We generated a mouse model in which PI3K is activated by forced recruitment of p110α to the membrane. Different transgenic lines expressing myristoylated p110α protein under the control of the epithelial-specific mouse mammary tumor virus promoter were selected according to different levels of PI3K activity and characterized. Delayed mammary gland involution and morphologic changes of the mammary ducts could be detected in young transgenic female mice. These changes were more pronounced in old animals, especially in mutiparous females, in which we observed increased ductal branching, alveolar hyperplasia, and intraductal neoplasia. We also observed a small percentage of mammary tumors. Crosses of myrp110α transgenic mice with heterozygous p53(+/−) knockout mice resulted in neither enhanced tumorigenesis nor in a stronger mammary gland phenotype. However, the CDK4 activating mutation (R24C) lead to increased tumorigenesis in transgenic myrp110α mice, emphasizing the postulated perturbation of the interaction of the CDK4/Rb/E2F cascade and the PI3K signaling in many human cancers. Interestingly, in tumors of myrp110α transgenic mice, we observed an increased phosphorylation of the estrogen receptor-α, a typical feature of human breast cancer. The model presented here will help to discover additional factors which influence the progression of preneoplastic lesions to tumors in the mammary gland and to explore antitumor therapies based on PI3K or estrogen receptor-α pathway inhibition. [Cancer Res 2008;68(23):9643–53]
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Furthermore, a mouse model in which direct activation of PI3K was accomplished by recruitment of p110α to the membrane resulted in alveolar hyperplasia and low penetrance tumorigenesis (45).”
From Mislocalization of the Cell Polarity Protein Scribble Promotes Mammary Tumorigenesis and Is Associated with Basal Breast Cancer (2014) · cites this paper as [45]
Citations
Cites
The phosphatidylinositol 3-Kinase–AKT pathway in human cancer
Vivanco, I., & Sawyers, C. L. (2002) · Nature Reviews Cancer · doi:10.1038/nrc839 · Cited by 6,056 · cited 2×
“Five different categories of phenotypes could be distinguished: (1) normal structure similar to the one of young virgin female mice; (2) increased number of ramifications and slightly increased alveolar size; (3) increased number of ramifications and strongly increased alveolar size; (4) extreme alveolar hyperprolifer…”
BackgroundAkt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery
Datta, S. R., Dudek, H., Tao, X., Masters, S., Fu, H., Gotoh, Y., & Greenberg, M. E. (1997) · Cell · doi:10.1016/s0092-8674(00)80405-5 · Cited by 5,689
High Frequency of Mutations of the PIK3CA Gene in Human Cancers
Samuels, Y., Wang, Z., Bardelli, A., Silliman, N., Ptak, J., Szabo, S., Yan, H., Gazdar, A., Powell, S. M., Riggins, G. J., et al. (2004) · Science · doi:10.1126/science.1096502 · Cited by 3,437
Regulation of Cell Death Protease Caspase-9 by Phosphorylation
Cardone, M. H., Roy, N., Stennicke, H. R., Salvesen, G. S., Franke, T. F., Stanbridge, E., Frisch, S., & Reed, J. C. (1998) · Science · doi:10.1126/science.282.5392.1318 · Cited by 2,481 · cited 1×
“PI3K and AKT inhibit cellular apoptosis by regulating the activity of apoptotic proteins such as BAD, caspase-9, and Mdm2 ( 37 , 38).”
BackgroundCrucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis
Chen, Z., Trotman, L. C., Shaffer, D., Lin, H.-K., Dotan, Z. A., Niki, M., Koutcher, J. A., Scher, H. I., Ludwig, T., Gerald, W., et al. (2005) · Nature · doi:10.1038/nature03918 · Cited by 1,993 · cited 1×
“Moreover, p53 is induced by PI3K activation (24) imposing a senescence blockade to tumorigenesis induced by PTEN loss in vivo (23).”
BackgroundMutation of the PIK3CA Gene in Ovarian and Breast Cancer
Campbell, I. G., Russell, S. E., Choong, D. Y. H., Montgomery, K. G., Ciavarella, M. L., Hooi, C. S. F., Cristiano, B. E., Pearson, R. B., & Phillips, W. A. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-2933 · Cited by 916 · cited 1×
“It has been described that constitutively active AKT may phosphorylate ERa, resulting in the alteration of gene expression and activity independently of estrogen (47, 48).”
BackgroundPhosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic
Kang, S., Bader, A. G., & Vogt, P. K. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408864102 · Cited by 823 · cited 2×
“They show similar catalytic activity ( 14 ) and similar capability to activate AKT (16).”
BackgroundMolecular mechanisms underlying ErbB2/HER2 action in breast cancer
Harari, D., & Yarden, Y. (2000) · Oncogene · doi:10.1038/sj.onc.1203973 · Cited by 633
Mutations in a signalling pathway
Parsons, D. W., Wang, T.-L., Samuels, Y., Bardelli, A., Cummins, J. M., DeLong, L., Silliman, N., Ptak, J., Szabo, S., Willson, J. K. V., et al. (2005) · Nature · doi:10.1038/436792a · Cited by 599 · cited 1×
“Five different categories of phenotypes could be distinguished: (1) normal structure similar to the one of young virgin female mice; (2) increased number of ramifications and slightly increased alveolar size; (3) increased number of ramifications and strongly increased alveolar size; (4) extreme alveolar hyperprolifer…”
BackgroundFreeman, D. J., Li, A. G., Wei, G., Li, H.-H., Kertesz, N., Lesche, R., Whale, A. D., Martinez-Diaz, H., Rozengurt, N., Cardiff, R. D., et al. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00021-7 · Cited by 515
Cited by
PIK3CA Mutation Associates with Improved Outcome in Breast Cancer
Kalinsky, K., Jacks, L. M., Heguy, A., Patil, S., Drobnjak, M., Bhanot, U. K., Hedvat, C. V., Traina, T. A., Solit, D., Gerald, W., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0632 · Cited by 401
“Wild-type 77% (73-81) 62% (57-67) 14% (11-18) 23% (18-27) vs Any PIK3CA mutation 85% (78-89) 71% (63-77) 0.”
BackgroundInfluentialDistinct functions of AKT isoforms in breast cancer: a comprehensive review
Hinz, N., & Jücker, M. (2019) · Cell Communication and Signaling · doi:10.1186/s12964-019-0450-3 · Cited by 355
“Several studies reported an association of AKT with breast cancer initiation [77], prognosis [16, 78], metastasis [79] and resistance to chemotherapy [80] as Hinz and Jücker Cell Communication and Signaling (2019) 17:154 Page 2 of 29”
BackgroundTargeting the PI3K/Akt/mTOR pathway in castration-resistant prostate cancer
Bitting, R. L., & Armstrong, A. J. (2013) · Endocrine-Related Cancer · doi:10.1530/erc-12-0394 · Cited by 311
Carnero, A. (2010) · Current Pharmaceutical Design · doi:10.2174/138161210789941865 · Cited by 272
“We have targeted p110 to the membrane activating PI3K in transgenic mice [156,157].”
BackgroundSelf-citationThe PTEN/PI3K/AKT Pathway in vivo, Cancer Mouse Models
Carnero, A., & Paramio, J. M. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00252 · Cited by 233
“In contrast, targeting p110α to the membranes of epithelial cells in the mammary glands predisposes the mammary glands to neoplastic transformation (119).”
BackgroundSelf-citation
Metadata
- Authors
- Renner, O., Blanco-Aparicio, C., Grassow, M., Cañamero, M., Leal, J. F. M., & Carnero, A.
- Affiliations
- Spanish National Cancer Research Centre (ES)
- 1Experimental Therapeutics Program and
- 2Biotechnology Program, Centro Nacional de Investigaciones Oncologicas, Madrid, Spain
- Venue
- Cancer Research
- Published
- 2008-12-01
- Volume
- 68
- Issue
- 23
- Pages
- 9643-9653
- ISSN
- 0008-5472 (ISSN-L)
- 1538-7445
- OpenAlex
- W2134009185
- Cited by
- 44
- References
- 50
- Citations by year
- 2023: 1 · 2022: 1 · 2020: 1 · 2019: 3 · 2017: 4 · 2016: 4 · 2015: 3 · 2014: 4 · 2013: 4 · 2012: 6
- FWCI
- 1.78
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Cancer Research (publishedVersion)
- PubMed (publishedVersion)
- DIGITAL.CSIC (Spanish National Research Council (CSIC)) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Keywords
- phosphatidylinositol 3-kinase, p110α, membrane recruitment, myristoylation, mammary gland, mammary gland involution, ductal branching, alveolar hyperplasia, mammary tumors, p53, breast cancer, precancerous lesions, tumor progression
- MeSH terms
- Animals, Cell Membrane, Cell Transformation, Neoplastic, Enzyme Activation, Female, Mammary Glands, Animal, Mammary Tumor Virus, Mouse, Mammary Neoplasms, Experimental, Mice, Transgenic, Phenotype, Promoter Regions, Genetic, Tumor Suppressor Protein p53, Retinoblastoma Protein, Transgenes, Phosphatidylinositol 3-Kinases, Genetic Predisposition to Disease, Cell Line, Tumor, Cyclin-Dependent Kinase 4, Mice, Class I Phosphatidylinositol 3-Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Activation of Phosphatidylinositol 3-Kinase by Membrane Localization of p110α Predisposes Mammary Glands to Neoplastic Transformation. https://app.cochat.ai/papers/10.1158/0008-5472.can-08-1539
- The paper
- Renner, O., Blanco-Aparicio, C., Grassow, M., Cañamero, M., Leal, J. F. M., & Carnero, A. (2008). Activation of Phosphatidylinositol 3-Kinase by Membrane Localization of p110α Predisposes Mammary Glands to Neoplastic Transformation. Cancer Research. https://doi.org/10.1158/0008-5472.can-08-1539
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.